ACHM


Also found in: Medical.
AcronymDefinition
ACHMAsphalt Concrete Hot Mix
ACHMAchromatopsia
ACHMAmerican College of Hyperbaric Medicine
ACHMAustralian Cultural Heritage Management (Hindmarsh, South Australia, Australia)
ACHMArenac County Historical Museum (Arenac County, Michigan)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Onset of symptoms is dependent upon dysfunction of the cone cells solely arising by the genetic mutations.7 ACHM is genetically heterogeneous.
Jeffrey Niezgoda, President of the ACHM. “The College is proud of the collaboration that went into creating this important document, and we believe the majority of our membership will agree that these criteria will advance the training of hyperbaric physicians and ultimately improve the quality of care delivered to patients."
"Denuncias de Amnistia Internacional" (1977), ACHM, MR/E-001, C-016, 000465; "Informe del Padre Miguel D'Escoto, M.M., ante el Subcomite de Asuntos Exteriores" (1977), ACHM, MR/E-001, C-016, 000476.
ACHM is shifting from principally physician-delivered or nurse-delivered CAM services to increased use of other alternative providers.
Research and development expense was USD3.4m for the three months ended 31 December 2014, a rise by USD1.2m over R&D of USD2.2m the same period in 2013, due to increased activity relating to its XLRS, ACHM, XLRP and other product candidates, including higher facilities and other costs associated with laboratory expansions.
Janssen Pharmaceutical of Johnson & Johnson (JNJ) announced a worldwide collaboration and license agreement with MeiraGTx (MGTX) to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio, including leading product candidates for achromatopsia, or ACHM, caused by mutations in either CNGB3 or CNGA3, and X-linked retinitis pigmentosa, or XLRP.
The two companies will collaborate in the clinical development of MeiraGTx's IRD pipeline, including product candidates for achromatopsia, or ACHM, caused by mutations in either CNGB3 or CNGA3 and X-linked retinitis pigmentosa.
He keeps a Buy rating on the shares but admits Applied Genetic "might be in the penalty box pending positive clinical data from the ACHM and/or XLRP programs to validate this thesis."